Oklahoma

State of Hepatitis C
Medicaid Access:

C

Oklahoma

Liver damage restrictions

Oklahoma imposes no liver damage requirements (F0 or greater) for preferred treatments (Epclusa, and Mavyret). Non-preferred regimens (Daklinza, Harvoni, Olysio, Sovaldi, Technivie, and Viekira PAK/XR) require moderate liver damage (F2 or greater). Additionally, many clinical issues including, but not limited to anemia, surgery, depression, obesity, epilepsy, psychosis, weight management, or severe concurrent medical diseases must be addressed before starting therapy.

Sobriety restrictions

Oklahoma requires screening and counseling for alcohol and substance use as well as the beneficiary to commit to abstain from alcohol and substance use during and after treatment. Patients must agree to random drug testing during treatment.

Prescriber restrictions

Oklahoma requires a prescription be written by or in consultation with a gastroenterologist, infectious disease, or transplant specialist.

Recommendations

  • Completely remove liver damage, sobriety and prescriber requirements.
  • Maintain transparency regarding hepatitis C coverage requirements.

Take Action

JOIN THE NETWORK

Join us in urging officials across the country to support policies that help Americans living with hepatitis C get cured.

Join the Network

SPREAD THE WORD

Access our infographics, social media toolkit and digital resources.

Spread the Word

SHARE YOUR STORY

Share your hepatitis C access story.

Share Your Story